CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 87.3%, higher than 95% of its Medical Devices peers (median 61%)
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
710.29MUSDvs all stocks (USD)
Revenue (TTM)
95.07MUSDvs all stocks (USD)
Profit Margin
-63.51%vs Medical Devices peers
52-Week Change
23.08%vs all stocks
Market Capitalization
710.29MUSDvs all stocks (USD)
Enterprise Value
617.02MUSDvs all stocks (USD)
Forward P/E
-17.66xvs Medical Devices peers
Price to Sales (TTM)
7.74xvs Medical Devices peers
Price to Book (MRQ)
5.22xvs Medical Devices peers
Enterprise to Revenue
6.49xvs Medical Devices peers
Enterprise to EBITDA
-9.69xvs Medical Devices peers
Gross Margin
87.27%vs Medical Devices peers
Profit Margin
-63.51%vs Medical Devices peers
Operating Margin
-78.30%vs Medical Devices peers
Return on Assets (TTM)
-20.73%vs Medical Devices peers
Return on Equity (TTM)
-37.53%vs Medical Devices peers
Revenue (TTM)
95.07MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.57USDUpdated Jul 18, 2026Quarterly Revenue Growth
29.30%vs Medical Devices peers
Gross Profit (TTM)
83.39MUSDvs all stocks (USD)
EBITDA (TTM)
-63.70MUSDvs all stocks (USD)
Net Income (TTM)
-60.37MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
29.30%vs Medical Devices peers
Operating Cash Flow (TTM)
-48.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-29.33MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
89.06MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
10.79MUSDFY2025 · Dec 31, 2025Gross Profit
78.27MUSDFY2025 · Dec 31, 2025Operating Income
-58.40MUSDvs all stocks (USD)
Pre-tax Income
-53.41MUSDFY2025 · Dec 31, 2025Income Tax Expense
0.00USDFY2025 · Dec 31, 2025Net Income
-53.41MUSDFY2025 · Dec 31, 2025EBIT
-51.52MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-50.18MUSDFY2025 · Dec 31, 2025Research & Development
19.14MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
117.53MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.89MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-53.41MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-43.47MUSDFY2025 · Dec 31, 2025Free Cash Flow
-44.24MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
40.48MUSDFY2025 · Dec 31, 2025Interest Paid
1.89MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-53.41MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.34MUSDFY2025 · Dec 31, 2025Stock-based Compensation
12.22MUSDFY2025 · Dec 31, 2025Other Non-cash Items
314.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-4.89MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.75MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-792.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-767.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-210.81MUSDFY2025 · Dec 31, 2025Sale of Investments
94.20MUSDFY2025 · Dec 31, 2025Other Investing Activity
-755.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-118.14MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-386.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-386.00KUSDFY2025 · Dec 31, 2025Shares Outstanding
37.86MSharesUpdated Jul 18, 2026Float Shares
26.06MSharesUpdated Jul 18, 2026Shares Short
1.98MSharesUpdated Jul 18, 2026Short Ratio
5.34daysvs all stocks
Short % of Shares Outstanding
8.03%vs all stocks
% Held by Insiders
12.79%vs all stocks
% Held by Institutions
86.91%vs all stocks
Total Cash (MRQ)
141.18MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.72USDUpdated Jul 18, 2026Total Debt (MRQ)
22.12MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1571xvs Medical Devices peers
Current Ratio (MRQ)
10.44xvs Medical Devices peers
Book Value per Share (MRQ)
3.72USDUpdated Jul 18, 2026Total Assets
195.80MUSDvs all stocks (USD)
Total Current Assets
186.72MUSDFY2025 · Dec 31, 2025Total Liabilities
40.47MUSDFY2025 · Dec 31, 2025Total Non-current Assets
9.09MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
21.28MUSDFY2025 · Dec 31, 2025Total Current Liabilities
19.19MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
40.48MUSDFY2025 · Dec 31, 2025Other Short-term Investments
118.78MUSDFY2025 · Dec 31, 2025Accounts Receivable
15.05MUSDFY2025 · Dec 31, 2025Inventory
7.29MUSDFY2025 · Dec 31, 2025Accounts Payable
2.84MUSDFY2025 · Dec 31, 2025Short-term Debt
1.10MUSDFY2025 · Dec 31, 2025Deferred Revenue
101.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
818.00KUSDFY2025 · Dec 31, 2025Long-term Debt
21.17MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
106.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-220.36MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
155.34MUSDvs all stocks (USD)
52-Week Low
10.85USDUpdated Jul 18, 202652-Week High
24.33USDUpdated Jul 18, 202652-Week Change
23.08%vs all stocks
50-Day MA
18.71USDUpdated Jul 18, 2026200-Day MA
18.13USDUpdated Jul 18, 2026Avg 10-Day Volume
341.65KSharesUpdated Jul 18, 2026Avg 30-Day Volume
359.88KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-1.62USDUpdated Jul 18, 2026Other Income / Expense
6.88MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 87.3%, higher than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.87Industry median: 0.61Industry P95: 0.85Peers compared: 102
Operating margin is -78.3%, lower than 95% of its Medical Devices peers (median 8.1%)Significant
Operating margin: -0.78Industry median: 0.08Industry P5: -0.73Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.87Profit Margin: -0.64
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.53
Altman Z-Score 9.57: safe zoneNotable
Altman Z-Score: 9.57
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen Lifotronic Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Wecome Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hvsen Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Obio Technology (Shanghai) Corp., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Beijing Beilu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Omeros Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Teyi Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Upi Semiconductor Corp.
1 interpretationLow-Leverage Liquidity Configuration
Jiangsu Hengli Hydraulic Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationLow-Leverage Liquidity Configuration